ResMed (RMD) Financial Analysis & Valuation | Quarter Chart
ResMed (RMD)
RMDPrice: $198.43
Fair Value: 🔒
🔒score
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respirat... more
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based softwar... more
Description
Shares
| Market Cap | $28.78B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Michael J. Farrell |
| IPO Date | 1995-06-02 | CAGR | 0.23% |
| Employees | 9,980 | Website | www.resmed.com |
| Div. Yield | 6.74% | Payout Ratio | 0.22% |
| Buy Back Yield | 11.66% | Total Yield | 18.4% |
RMD chart loading...
Fundamentals
Technicals
| Enterprise Value | $30.67B | P/E Ratio | 18.42 |
| Forward P/E | 16.39 | PEG Ratio | 1.82 |
| P/S Ratio | 0.94 | P/B Ratio | 0.8 |
| P/CF Ratio | 2.77 | P/FCF Ratio | 2.95 |
| EPS | $10.77 | EPS Growth 1Y | 16.05% |
| EPS Growth 3Y | 76.15% | EPS Growth 5Y | 230.35% |
| Revenue Growth 1Y | 10.28% | Gross Margin | 0.62% |
| Operating Margin | 0.34% | Profit Margin | 0.27% |
| ROE | 0.24% | ROA | 0.17% |
| ROCE | 0.26% | Current Ratio | 3.01 |
| Quick Ratio | 2.33 | Cash Ratio | 1.23 |
| Debt/Equity | 0.13 | Interest Coverage | 65.4 |
| Altman Z Score | 10.36 | Piotroski Score | 7 |